ArticleCancers2022

Sabizabulin, a Potent Orally Bioavailable Colchicine Binding Site Agent, Suppresses HER2+ Breast Cancer and Metastasis.

Raisa I Krutilina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.